2KSW
 
 | | Backbone 1H, 13C, and 15N Chemical Shift Assignments for Oryctin | | Descriptor: | Oryctin | | Authors: | Horita, S, Ishibashi, J, Nagata, K, Miyakawa, T, Yamakawa, M, Tanokura, M. | | Deposit date: | 2010-01-14 | | Release date: | 2010-07-14 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Isolation, cDNA cloning, and structure-based functional characterization of oryctin, a hemolymph protein from the coconut rhinoceros beetle, Oryctes rhinoceros, as a novel serine protease inhibitor
J.Biol.Chem., 285, 2010
|
|
1IYC
 | | Solution structure of antifungal peptide, scarabaecin | | Descriptor: | scarabaecin | | Authors: | Hemmi, H, Ishibashi, J, Tomie, T, Yamakawa, M. | | Deposit date: | 2002-08-05 | | Release date: | 2003-06-24 | | Last modified: | 2023-12-27 | | Method: | SOLUTION NMR | | Cite: | Structural Basis for New Pattern of Conserved Amino Acid Residues Related to Chitin-binding in the Antifungal Peptide from the Coconut Rhinoceros Beetle Oryctes rhinoceros
J.BIOL.CHEM., 278, 2003
|
|
1KV4
 | | Solution structure of antibacterial peptide (Moricin) | | Descriptor: | moricin | | Authors: | Hemmi, H, Ishibashi, J, Hara, S, Yamakawa, M. | | Deposit date: | 2002-01-25 | | Release date: | 2002-05-22 | | Last modified: | 2024-05-29 | | Method: | SOLUTION NMR | | Cite: | Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori.
FEBS Lett., 518, 2002
|
|
1X22
 | | Solution structure of a novel moricin analogue, an antibacterial peptide from a lepidopteran insect, Spodoptera litura | | Descriptor: | moricin | | Authors: | Oizumi, Y, Hemmi, H, Minami, M, Asaoka, A, Yamakawa, M. | | Deposit date: | 2005-04-18 | | Release date: | 2005-09-06 | | Last modified: | 2024-05-01 | | Method: | SOLUTION NMR | | Cite: | Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura
Biochim.Biophys.Acta, 1752, 2005
|
|
7VBU
 | | Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 5 | | Descriptor: | 8-cyclopropyl-2-methyl-9H-pyrido[2,3-b]indole, ACETATE ION, CHLORIDE ION, ... | | Authors: | Orita, T, Doi, S, Iwanaga, T, Fujishima, A, Adachi, T. | | Deposit date: | 2021-09-01 | | Release date: | 2022-02-16 | | Last modified: | 2023-11-29 | | Method: | X-RAY DIFFRACTION (1.89 Å) | | Cite: | Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors.
Bioorg.Med.Chem., 52, 2021
|
|
7VBX
 | | Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 20 | | Descriptor: | (3~{S})-3-[5-(8-cyclopropyl-2-methyl-9~{H}-pyrido[2,3-b]indol-3-yl)-1,3,4-oxadiazol-2-yl]-4-methyl-~{N}-[(1~{R})-1-phenylethyl]pentanamide, ACETATE ION, CHLORIDE ION, ... | | Authors: | Orita, T, Doi, S, Iwanaga, T, Fujishima, A, Adachi, T. | | Deposit date: | 2021-09-01 | | Release date: | 2022-02-16 | | Last modified: | 2023-11-29 | | Method: | X-RAY DIFFRACTION (2.6 Å) | | Cite: | Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors.
Bioorg.Med.Chem., 52, 2021
|
|
7VBV
 | | Crystal structure of human pyruvate dehydrogenase kinase 2 in complex with compound 7 | | Descriptor: | ACETATE ION, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Orita, T, Doi, S, Iwanaga, T, Fujishima, A, Adachi, T. | | Deposit date: | 2021-09-01 | | Release date: | 2022-02-16 | | Last modified: | 2023-11-29 | | Method: | X-RAY DIFFRACTION (2.21 Å) | | Cite: | Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors.
Bioorg.Med.Chem., 52, 2021
|
|
